Tag Archives: Treatment

FDA Approves Baqsimi (glucagon) Nasal Powder for the Treatment of Severe Hypoglycemia

FDA Approves Baqsimi (glucagon) Nasal Powder for the Treatment of Severe Hypoglycemia Print this page July 24, 2019 — The U.S. Food and Drug Administration today approved Baqsimi nasal powder, the first glucagon therapy approved for the emergency treatment of severe hypoglycemia that can be administered without an injection. Severe hypoglycemia occurs when a patient’s… Read More »